Quince Therapeutics Team
Quince Therapeutics
Last updated: February 23, 2026
Quince is developing treatments for Alzheimers and other degenerative disorders. Alzheimers Healthcare
Sequoia, Post-IPO, $130M valuation
Quince is developing treatments for Alzheimers and other degenerative disorders. Alzheimers Healthcare
Sequoia, Post-IPO, $130M valuation
- IPO • Sequoia, Post-IPO, $130M valuation
Founder Intelligence Brief: Quince Therapeutics Team
This profile is built to help readers move from a founder name to decision-ready context. Quince Therapeutics Team is mapped to Quince Therapeutics in the Alzheimers category, with current stage context as Ipo. The primary operating market is San Francisco Bay Area, California, USA, which connects this profile directly to regional ecosystem pages and related industry hubs.
Funding visibility currently shows $130.00M, with the latest mapped round as IPO (Sequoia, Post-IPO, $130M valuation). This makes it easier to evaluate growth narrative against capital stage rather than reading isolated updates without baseline context.
For deeper research, combine this founder page with the company profile, company news hub, country newsroom and Alzheimers startup list. This route gives a cleaner picture of execution, market demand, and competitive movement.
Research flow
- Validate company baseline on company intelligence.
- Compare market peers via Alzheimers industry routes and Ipo stage pages.
- Track fresh updates in newsroom coverage and signals feed.
Operating context
- Geography: United States directory.
- Stage signal: Ipo funding coverage.
- Hiring status: Open Roles.
Related Founders
More founders in Alzheimers.
No related founders available yet.
Want to get featured on 100Xfounder?
Get your founder profile published with verified funding and hiring context.
Related Pillar Pages
Access the country, industry, stage, startup taxonomy, and newsroom routes connected to this founder.
FAQs About Quince Therapeutics Team
Common questions people ask about this profile.
Who is Quince Therapeutics Team?
Quince Therapeutics Team is the founder profile listed on 100Xfounder for Quince Therapeutics, tracked for market signals, company intelligence, and operator-level context.
What does Quince Therapeutics do?
Quince is developing treatments for Alzheimers and other degenerative disorders. Alzheimers Healthcare
Where is Quince Therapeutics based?
Quince Therapeutics is listed as operating from San Francisco Bay Area, California, USA.
What is the current funding stage of Quince Therapeutics?
Quince Therapeutics is currently categorized at Ipo on 100Xfounder. Funding signal: Sequoia, Post-IPO, $130M valuation
What is the latest funding round for Quince Therapeutics?
The latest tracked round for Quince Therapeutics is IPO Sequoia, Post-IPO, $130M valuation. Total tracked rounds: 1.
Is Quince Therapeutics hiring right now?
Current hiring signal for Quince Therapeutics: Open Roles.
Is Quince Therapeutics Team's profile verified?
Yes. Quince Therapeutics Team's profile is marked as verified on 100Xfounder as of July 28, 2026.
How can I connect with Quince Therapeutics Team?
You can use the profile action buttons and listed links on 100Xfounder. Contact context is provided with business relevance and profile metadata for www.cortexyme.com.
What technologies are associated with Quince Therapeutics?
Quince Therapeutics is associated with AWS, React, Python, and PostgreSQL based on current profile intelligence.